Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

NovaBridge Biosciences (NBP) Assets Average (2020 - 2025)

NovaBridge Biosciences (NBP) has 6 years of Assets Average data on record, last reported at $269.0 million in Q4 2025.

  • On a quarterly basis, Assets Average rose 20.79% to $269.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $269.0 million, a 20.79% increase, with the full-year FY2025 number at $236.6 million, down 18.66% from a year prior.
  • Assets Average reached $269.0 million in Q4 2025 per NBP's latest filing, up from $242.1 million in the prior quarter.
  • Over the last five years, Assets Average for NBP hit a ceiling of $954.0 million in Q2 2021 and a floor of $207.8 million in Q2 2025.
  • A 5-year average of $478.4 million and a median of $269.0 million in 2025 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: surged 255.62% in 2021, then crashed 34.8% in 2023.
  • Tracing NBP's Assets Average over 5 years: stood at $914.1 million in 2021, then dropped by 27.91% to $659.0 million in 2022, then decreased by 19.8% to $528.5 million in 2023, then crashed by 57.87% to $222.7 million in 2024, then grew by 20.79% to $269.0 million in 2025.
  • Business Quant data shows Assets Average for NBP at $269.0 million in Q4 2025, $242.1 million in Q3 2025, and $207.8 million in Q2 2025.